Home Newsletters Extracellular Matrix News Harvard University Licenses Kidney Engineering Technology to Trestle Biotherapeutics to Facilitate New...

Harvard University Licenses Kidney Engineering Technology to Trestle Biotherapeutics to Facilitate New Kidney Replacement Therapies

0
A newly launched startup is building upon innovations developed over several years at the Wyss Institute, Harvard John A. Paulson School of Engineering & Applied Sciences, and Brigham and Women’s Hospital to engineer functional kidney tissue for renal repair and replacement therapy.
[Wyss Institute]
7992332 {7992332:BBBBBBBB} apa 50 1 172211 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Press Release
Exit mobile version